L'Air Liquide S.A. (AIL.DE) - Deep Dive Research Report

Research Date: May 17, 2026 Primary Listing: Euronext Paris (AI.PA) | German Cross-Listing: AIL.DE Sector: Basic Materials - Industrial Gases

1. What the Company Does

In 1902, a French engineer named Georges Claude solved a commercially irrelevant problem: how to cool air to below minus 190 degrees Celsius and then fractionally distill it to separate the oxygen from the nitrogen and argon. Claude's insight was thermodynamic. Paul Delorme's insight was economic. Delorme gathered 24 private investors, founded L'Air Liquide on November 8, 1902, and transformed Claude's cryogenic curiosity into one of the most durable industrial businesses in history.

The core of the business is simple to state but expensive to replicate. Air is free. Separating it into useful industrial gases is not. Almost every major industrial process - steelmaking, semiconductor manufacturing, hospital care, petroleum refining, food packaging - requires gases in specific purities, pressures, and volumes that cannot practically be sourced from the atmosphere without specialised infrastructure. Air Liquide builds, owns, and operates that infrastructure, and then sells the gases on long-term contracts.

The value proposition differs meaningfully by customer type. For a steel mill, Air Liquide builds a dedicated air separation unit adjacent to the blast furnace, connects it by pipeline, and supplies oxygen continuously for the next 15 to 20 years under a take-or-pay contract. The steel company could theoretically build the unit itself, but a gas company's core competency - operating dozens of such plants across industrial clusters, optimising logistics, managing purity certification - delivers lower total cost than any industrial conglomerate can match internally. So they outsource the gases entirely.

For a hospital, Air Liquide supplies medical-grade oxygen and manages the pipeline distribution inside the building. For a patient with chronic obstructive pulmonary disease living at home, Air Liquide provides an oxygen concentrator, monitors the patient remotely via connected devices, and coordinates clinical interventions when readings fall outside normal ranges. For a semiconductor fab building the most advanced AI chips, Air Liquide supplies ultra-pure nitrogen - gas so clean that a single molecule of contamination per trillion can ruin a chip die - and manages the gas distribution infrastructure inside the cleanroom.

Walk through what Air Liquide actually does for a single customer: a large semiconductor fab operator in Japan that signed a contract in April 2026. Air Liquide will build, at its own cost, industrial gas production facilities adjacent to the fab. When construction completes - expected by end 2028 - Air Liquide will deliver large volumes of ultra-pure nitrogen, oxygen, and argon continuously. The fab never touches the production process. Air Liquide certifies purity, monitors delivery, and is contractually accountable for supply continuity. The €200 million capital investment Air Liquide made to win that contract disappears into the fab's cost structure as a per-unit gas price - and the revenue flows for the duration of the chip manufacturer's operation at that site.

That pattern - upfront capital from Air Liquide, recurring revenue from the customer, extremely high switching costs once the infrastructure is in place - is the business model repeated across 65,000 employees, 59 countries, and approximately 4.3 million customers and patients.

"Our resilient and agile business model is the key to our continued growth." - François Jackow, CEO, Q1 2026 concall (April 28, 2026)

2. Business Segments

Large Industries (approximately 26% of Gas & Services revenue)

Large Industries is the oldest and most capital-intensive part of Air Liquide's business. It supplies oxygen, nitrogen, argon, hydrogen, carbon monoxide, and synthesis gas in bulk - by pipeline or via dedicated on-site production units - to some of the heaviest industries in the world: steel mills, petroleum refineries, petrochemical complexes, and ammonia plants.

What it does. An air separation unit (ASU) in a Large Industries context is a factory-sized installation, often costing tens to hundreds of millions of euros, that sits within or adjacent to the customer's industrial complex. Air is compressed, purified, and cooled to cryogenic temperatures - below minus 185 degrees Celsius - at which point its components liquefy at different temperatures. Oxygen separates from nitrogen from argon. The resulting gases are piped directly to the customer's process, with pipeline connections that can span industrial basins across hundreds of kilometres.

Air Liquide's global pipeline network exceeds 9,000 kilometres - the longest industrial gas pipeline infrastructure in the world. In the US Gulf Coast alone, Air Liquide operates a pipeline system running nearly 2,000 miles through Texas and Louisiana, supplying oxygen, nitrogen, and hydrogen to refineries and chemical plants. This physical network is not replicable. A new entrant cannot build 9,000 km of pipeline. Existing customers cannot switch to a competitor without dismantling their supply infrastructure and rebuilding it around a different provider's network.

The core capability. Large Industries requires mastery of cryogenic engineering, pipeline logistics, and long-term project financing. Building a new air separation unit and connecting it to a customer's operations takes 2-4 years from contract signing to first gas delivery. Air Liquide has done this hundreds of times across dozens of countries and refines its execution on every cycle. The institutional knowledge is embodied in engineering methodologies, supplier relationships, and project management teams that a new entrant would take decades to assemble.

Why it exists separately. The economics are fundamentally different from merchant gas businesses. Revenue is highly predictable - contracts are 15-20 years, take-or-pay, indexed to energy and inflation - but the upfront capital is enormous. The segment's risk-return profile resembles infrastructure more than manufacturing: high asset intensity, modest growth from volume, incremental return from efficiency.

Competitive position. Linde is Air Liquide's primary competitor in this segment globally. Both have entrenched pipeline assets in different geographies. The geography of pipeline networks is so specific that competition often resolves to: which company's pipes already pass nearest to the proposed customer site? In many industrial basins, there is effectively no contest - Air Liquide supplies the basin, and a new entrant would face impossible economics.

Current performance. Large Industries showed modest softness in Europe through 2025 (-1.4% comparable in EMEA), reflecting weak demand from the region's heavy industry. The Americas were stronger (+4.8% comparable at the group level in Q3 2025), supported by new project start-ups and US Gulf Coast activity. The new Hyundai-POSCO Louisiana low-carbon steel JV, for which Air Liquide committed more than $350 million in investment (announced Q1 2026), will add significant Large Industries volume from late 2020s.

Industrial Merchant (approximately 46% of Gas & Services revenue)

Industrial Merchant is the most commercially diverse and logistically complex part of the business. It serves approximately 2 million customers - predominantly small and medium-sized enterprises - with gases delivered in bulk liquid form via cryogenic road tankers, or in high-pressure cylinders. Customers range from welding workshops and food manufacturers to laboratories, hospitals, and industrial users too small for a dedicated pipeline.

What it does. A merchant customer - say, a metal fabrication shop that welds components - buys mixed shielding gas (argon-CO2 mix, commonly called MIG gas) in steel cylinders. Air Liquide manages the cylinder fleet: filling, testing, certification, and logistics. Alternatively, a food manufacturer that flash-freezes products receives bulk liquid nitrogen in a cryogenic tank that Air Liquide tops up on a regular delivery schedule. A hospital in a mid-sized city receives bulk liquid oxygen delivered by tanker, stored in an insulated tank on hospital grounds, and evaporated on demand.

This segment is more commoditised than Large Industries at the product level, but Air Liquide differentiates through service. The ability to deliver reliably on a 24/7 basis, manage a complex cylinder and tanker fleet across thousands of customers, and offer application expertise (which gas formulation for which welding process, what pressure, what purity) is the value-add that keeps customers from switching to a cheaper cylinder filler down the street.

The core capability. Industrial Merchant is fundamentally a logistics and route optimisation business layered on top of gas production. Air Liquide uses advanced scheduling algorithms to optimise delivery routes, reduce empty miles, and time refills before customers run out. The company explicitly credits this operational capability as a driver of its margin improvement program (the "ADVANCE" plan). Efficiencies generated from route optimisation, pricing discipline, and asset utilisation are measured quarterly and reported publicly - they reached a record €631 million in 2025, up 27% versus 2024.

Pricing discipline. In Industrial Merchant, Air Liquide manages pricing more actively than in Large Industries (where contracts are indexed). The segment posted a consistent price effect of +2.0-3.1% in 2025, demonstrating pricing power in an inflationary environment. Volume growth was softer in Europe (weak industrial production) but robust in the Americas.

Geographic variation. The Americas division is Air Liquide's most dynamic merchant operation, driven by its 2016 Airgas acquisition (the largest-ever deal in the gas industry at $13.4 billion), which created a national cylinder distribution network in the United States that no competitor matches. Airgas gave Air Liquide a branch network across all 50 US states, serving customers from welding supply shops to universities.

Competitive position. Linde, Air Products, and Messer compete in Industrial Merchant, but the Airgas network gives Air Liquide a significant structural advantage in the US. In Europe, competition is more fragmented. Regional gas companies compete in specific countries. Air Liquide's scale provides route density advantages that smaller competitors cannot match.

Healthcare (approximately 18% of Gas & Services revenue)

Healthcare is Air Liquide's most consistent growth segment and the one most insulated from industrial cycles. Demographic trends - aging populations, rising prevalence of chronic respiratory disease, increasing demand for home-based care - are secular drivers that do not correlate with steel production or semiconductor capex.

What it does. Healthcare has three distinct activities:

Home Healthcare is the largest and fastest-growing sub-segment. Air Liquide supports approximately 2.3 million chronic patients living at home across Europe and increasingly globally. These patients have conditions like COPD, sleep apnea, respiratory failure, Parkinson's disease, or diabetes. Air Liquide supplies the equipment (oxygen concentrators, ventilators, CPAP machines, insulin pumps), manages delivery and maintenance, provides clinical monitoring via connected devices (100,000 patients already using the app), and coordinates with physicians. The Madrid regional health system signed a major contract in September 2025 for Air Liquide to support 70,000 patients living with respiratory conditions at home - a single deal that adds the equivalent of a small European country's patient base.

Hospital Healthcare supplies medical gases - oxygen, nitrous oxide (for anesthesia), medical air, helium (for MRI cooling), and carbon dioxide - to 20,000 hospitals and care facilities across 80+ countries. Air Liquide manages the gas infrastructure inside the hospital, including pipeline distribution, pressure monitoring, and supply redundancy. Hospitals are essentially captive customers once the infrastructure is installed.

Specialty Ingredients is a smaller sub-segment providing active ingredients and specialty gases for pharmaceutical manufacturing, cosmetics, and nutritional products. It includes SEPPIC, a specialty chemicals unit Air Liquide acquired in the 1980s.

The core capability. Home Healthcare is a service business masquerading as a gas business. The competitive advantage is not the oxygen - it is the ability to coordinate clinical care at scale: thousands of nurses and respiratory therapists, a certified medical device supply chain, regulatory compliance across dozens of European healthcare systems, and connected digital infrastructure. Air Liquide is the only industrial gas company that has built this capability at meaningful scale. Linde and Air Products have largely exited or limited their healthcare activities, leaving Air Liquide with a strategic differentiation that compounds over time.

Why it exists separately. Healthcare clients are not industrial buyers. Reimbursement comes from government health systems, not procurement departments. Regulatory approval is required for medical-grade gas supply and home healthcare service provision. Patient data is protected under GDPR and health privacy laws. The entire commercial, operational, and regulatory structure is distinct from the industrial business.

Competitive position within Healthcare. Air Liquide's home healthcare business competes with specialist home healthcare providers (Lincare in the US, various country-specific operators in Europe) and with private equity-backed care consolidators. The gas company's advantage is the combination of gas supply and care services - a fully integrated model where the competitor must source gas from someone like Air Liquide anyway. Tenders are won on quality of clinical outcomes and cost efficiency.

Growth trajectory. Healthcare has grown 4-5% comparable in every quarter across the four concalls reviewed. This is the segment that provides the floor for the group in any industrial recession. The H1 2025 results presentation described it as "strongly independent from the economic environment."

Electronics (approximately 9% of Gas & Services revenue)

Electronics is the smallest segment by revenue but potentially the most strategically important over the next decade. It supplies the gases that semiconductor fabs cannot make chips without - and the economics of each new fab cycle require Air Liquide to make substantial upfront investments to win contracts that then produce recurring revenue for 10-15 years.

What it does. Every semiconductor wafer goes through hundreds of process steps. Almost all of them require ultra-pure gases. Nitrogen is used to purge oxygen from chambers and prevent oxidation. Hydrogen is used in epitaxial growth. Chlorine, NF3, WF6, and dozens of specialty chemical precursors are used to etch, deposit, clean, and passivate layers at the sub-nanometre scale.

Air Liquide Electronics supplies two categories of product. Carrier gases (nitrogen, oxygen, argon, hydrogen, helium) must meet ultra-high purity specifications - typically 99.9999% or "six nines" purity, meaning fewer than one part per million of any impurity. Specialty and advanced materials (NF3 for chamber cleaning, tungsten hexafluoride for metal interconnects, silane for silicon deposition, and dozens of other precursors) are chemically complex molecules that Air Liquide manufactures or sources globally and delivers in certified containers with full traceability.

The Electronics segment also includes equipment and systems - the gas delivery infrastructure inside the fab: gas cabinets, valve manifold boxes, scrubbers, abatement systems. These are high-value capital items sold when a fab is built and upgraded as process nodes advance.

The core capability. Semiconductor fabs have zero tolerance for gas supply disruption or contamination. A purity excursion that contaminates a process chamber can destroy a day's production worth tens of millions of dollars. Air Liquide's electronics business has spent decades building the quality management systems, analytical capability, and supply chain redundancy required to serve customers at this tolerance level. The molecular beam epitaxy team, the metrology lab, the on-site gas purification units - these are not things a new entrant builds quickly.

Air Liquide is also developing specialty materials in-house. The molybdenum plant inaugurated in South Korea in 2025 produces precursor materials for advanced logic and memory chips - materials that had previously been sourced from a handful of Japanese and Korean chemical companies. Vertical integration into precursor chemistry is a capability that took years to build.

Revenue lumpiness. The segment shows volatility at the reported revenue level because equipment/installation revenues arrive as one-time items when a fab opens. The carrier gas business - the recurring, high-quality revenue stream - has been growing strongly: +10% comparable in H1 2025. Management regularly strips out equipment/installation to show the underlying trend.

Investment backlog. Approximately €1.6 billion of Air Liquide's record €5.5 billion investment backlog (as of Q1 2026) is in Electronics. Major contracts include:

• Germany (Silicon Saxony): €250M+ to build three ASUs and two hydrogen production units for semiconductor cluster, operational 2027
• Japan: €200M to support a leading semiconductor manufacturer producing next-generation AI chips, operational by end-2028
• Singapore (VSMC joint venture): €130M for high-purity gas supply
• Idaho (Micron): new industrial gas production facility
• Taiwan Advanced Materials plant: inaugurated in Q1 2026

Engineering & Technologies / Global Markets & Technologies (residual of Group revenue)

This segment is primarily internal - Air Liquide's engineering arm that designs, engineers, and constructs gas plants for the Group's own Large Industries and Electronics operations. It has ~3,000 engineers across 15 global engineering centres.

Externally, it takes on third-party engineering contracts for hydrogen production plants, CO2 capture systems, and gas processing facilities. Order intake grew 38% year-on-year in H1 2025, reflecting the surge in demand for hydrogen and decarbonisation infrastructure globally.

The hydrogen dimension of this segment is worth separate attention. Air Liquide is one of the world's largest producers and distributors of hydrogen, with operations spanning traditional industrial hydrogen (grey, from steam methane reforming) and the growing renewable and low-carbon hydrogen market. The ELYgator project in Rotterdam - a 200 MW electrolyzer that received final investment decision in July 2025 - will produce 23,000 tonnes of renewable hydrogen annually, enough to serve industrial customers and heavy-duty mobility users across the Netherlands and Belgium. Air Liquide is also in a joint venture with TotalEnergies for a second 250 MW electrolyzer in the Netherlands, announced in February 2025. Together, these would be among the largest PEM/alkaline electrolysis installations in the world.

Segment Summary

3. Products and Business Detail

Atmospheric gases are the primary products. Air contains 78% nitrogen, 21% oxygen, and 1% argon. An air separation unit (ASU) compresses incoming air, removes moisture and CO2 in a purification system, then sends the clean dry air through a cryogenic heat exchanger - cooling it progressively until it reaches liquid state. Liquid air then enters a distillation column where the different boiling points of oxygen (-183°C), argon (-186°C), and nitrogen (-196°C) allow fractional separation. The products are drawn off as liquid or warmed back to gas and compressed.

The scale of an industrial ASU is imposing: the largest units stand 60 metres tall, weigh thousands of tonnes, and produce several thousand tonnes of oxygen and nitrogen per day. Air Liquide designs these plants internally through its engineering centres, and has built several hundred large ASUs globally over its 120-year history.

Industrial hydrogen is the second major product family. Hydrogen is produced at scale through steam methane reforming (SMR), where natural gas reacts with steam over a catalyst at high temperature. Air Liquide has been building SMR units since its 2007 acquisition of Lurgi, a German engineering company specialised in gasification and reforming. The US Gulf Coast hydrogen network (approximately 300 miles of pipeline) is the largest merchant hydrogen infrastructure in North America.

Renewable and low-carbon hydrogen is the emerging category. Water electrolysis uses electricity to split H2O into hydrogen and oxygen. When powered by renewables, the hydrogen is "green." When using low-carbon electricity (nuclear or with CCS on the SMR), it is "blue" or "low-carbon." Air Liquide is building large-scale electrolyzers (ELYgator at 200 MW and the TotalEnergies JV at 250 MW in the Netherlands), both expected operational by 2027-2028. These are among the largest electrolyzer projects in the world.

Medical and food-grade gases are atmospheric gases produced to pharmaceutical-grade purity specifications, with full traceability and quality management systems. Medical oxygen for hospitals must meet pharmacopoeia standards in each national market. Food-grade CO2 (used in beverage carbonation, food packaging modified atmosphere) requires specific purity certifications. These are the same molecules as industrial gases but produced and delivered under entirely different quality and regulatory regimes.

Electronics specialty materials are the most technically complex and highest-margin product family. NF3 (nitrogen trifluoride) is used to clean chemical vapour deposition chambers between wafer runs - billions of dollars of fabs cannot run without consistent NF3 supply. WF6 (tungsten hexafluoride) deposits tungsten metal in the tiny vias (interconnect holes) between chip layers - without WF6, no tungsten, no working chip. Air Liquide manufactures NF3 at its plant in St-Priest, France, and sources WF6 globally. Its molybdenum precursor plant in South Korea (inaugurated 2025) marks a move into materials for advanced 3D NAND and logic nodes.

Gas delivery systems for electronics include: gas cabinets (self-contained units housing cylinders with pressure regulation and safety systems), valve manifold boxes (for switching between cylinders without process interruption), and exhaust treatment/abatement systems that scrub toxic gases before they reach atmosphere. These are engineered products sold alongside gas supply contracts. Revenue is project-based (when a fab expands or opens) but supports the recurring gas supply relationship.

Healthcare equipment and digital services: Air Liquide Medical Systems designs and manufactures oxygen concentrators, ventilators, CPAP/BiPAP machines, and insulin infusion pumps. These devices are deployed in patients' homes and connected to Air Liquide's monitoring platform. The platform generates alerts when a patient's usage deviates from expected patterns, enabling clinical intervention. 100,000 patients were using the app in 2025, and the company is actively expanding this digital infrastructure.

Geographies and exports. Air Liquide operates in 59 countries, with a roughly balanced split between three regions. The Americas (~39% of Gas & Services revenue in H1 2025), anchored by the US Airgas network, is the most dynamic region. EMEA (~41%) is the historical home market, mature and margin-rich but exposed to European industrial weakness. Asia-Pacific (~20%) is the growth region, with South Korea (now leading position after DIG Airgas), China, Japan, and Singapore all significant.

The DIG Airgas acquisition, completed January 2026, made Air Liquide the industrial gas leader in South Korea - the fourth-largest industrial gas market globally - at an enterprise value of approximately €2.85 billion. South Korea's semiconductor (Samsung, SK Hynix) and steel (POSCO, Hyundai) industries are among the most gas-intensive in the world. The combined business had approximately €900 million in annual sales.

4. Customers

Large Industries customers are among the most capital-intensive businesses in the global economy. The buying decision for a new large industrial gas supply contract sits with the CFO, operations director, and procurement team of a steel company, refinery, or chemical plant. The decision process takes months to years. Air Liquide must demonstrate technical capability (can the plant be built to specification?), financial strength (can they fund the project and sustain the relationship for 20 years?), and operational track record (have they delivered reliably at comparable sites elsewhere?).

Once signed, these customers are essentially captive. The pipeline connecting a blast furnace to an Air Liquide oxygen plant is dedicated infrastructure. Switching would require the customer to either find an alternative pipeline route - which typically does not exist - or build a new ASU internally, costing hundreds of millions and years of construction. Contract structures reinforce this: take-or-pay clauses require customers to pay for minimum quantities even in downturns, and energy cost pass-throughs insulate Air Liquide from feedstock price swings. The contracts are also indexed to inflation, so real returns are maintained over the contract life.

New Large Industries customers announced in 2025-2026 include the Hyundai-POSCO Louisiana low-carbon steel joint venture, where Air Liquide committed over $350 million - its largest single US investment - to supply gases for a plant that will produce steel with significantly lower CO2 emissions than conventional blast furnace routes.

Industrial Merchant customers are typically small and medium enterprises. A welding shop buys a few cylinders per month. A food processing plant takes a bulk nitrogen delivery every few weeks. Switching costs are lower here than in Large Industries, but still meaningful. Cylinder equipment may be on rental from Air Liquide. Gas quality certifications from an existing supplier save the customer the cost of re-qualifying a new supplier. Delivery reliability is critical in time-sensitive operations (a food plant cannot stop its packaging line for a delayed gas delivery).

The breadth of the customer base - approximately 2 million customers - provides extraordinary diversification. No single merchant customer is material to group revenue. The commercial team is large and distributed, managed through a national network of branches (particularly in the US, where Airgas's branch network covers all 50 states), supported by digital ordering and logistics platforms.

Electronics customers are a handful of the world's most powerful manufacturers: TSMC, Samsung, SK Hynix, Micron, Intel, and the equipment makers (ASML, Applied Materials, Lam Research) who specify gas requirements for their tools. These are not price-sensitive buyers in the ordinary sense. The cost of an NF3 shortage that shuts a fab for one day runs into tens of millions of dollars in lost production. Customers pay premium prices for supply certainty and quality.

Qualification is the most powerful lock-in mechanism in the electronics segment. Each gas supplier must undergo a rigorous qualification process at every customer fab - analytical testing, process integration testing, regulatory review. Changing gas suppliers in a qualified process requires re-qualification, which can take 12-18 months and risks process yield. Once Air Liquide is qualified at a node (a specific chip manufacturing technology), it tends to stay qualified and rolls forward to the next node.

Healthcare customers fall into two categories. Hospitals and health systems sign multi-year contracts for medical gas supply and distribution management - procurement teams make decisions, but medical directors and infection control officers influence the choice of supplier, favouring proven reliability. Home healthcare patients are typically acquired through referral from hospital respiratory or sleep medicine departments, and their primary relationship is with the clinical care team, not a procurement function. Government health systems reimburse most home healthcare costs in Europe, creating a three-party relationship between Air Liquide, the patient, and the health insurer/government.

The Spanish Madrid regional contract (2025) for 70,000 respiratory patients is an example of large-scale healthcare procurement: a regional health authority goes to tender, evaluates suppliers on clinical quality, service breadth, cost, and scale, and awards a contract that brings an entire regional patient population under one provider's care.

5. Competitive Landscape

The industrial gases industry is an oligopoly by design. The capital requirements for building air separation infrastructure, the geographic specificity of pipeline networks, and the regulatory complexity of gas certifications create barriers to entry that have kept the global market consolidated around five companies for decades.

Linde plc (LIN) is the world's largest industrial gas company by revenue, formed from the 2018 merger of Germany's Linde AG and the US's Praxair. Linde consistently generates higher operating margins than Air Liquide, which analysts attribute to its superior cost discipline in engineering and projects, stronger pricing in some markets, and the operational benefits of the Praxair culture (Praxair had historically been the most efficient margin-generator in the industry). Linde dominates North America, has a strong presence in Europe, and is well-positioned in Asia. Its merger with Praxair was transformative - creating a company that is roughly 25-30% larger than Air Liquide by revenue. Air Liquide's primary strategic imperative under the ADVANCE plan has been to close this margin gap, and the 360 basis point improvement since 2022 is direct evidence of that effort.

Air Products and Chemicals (APD) is the third-largest global player, headquartered in Pennsylvania. Air Products made a strategic decision in 2021-2022 to exit packaged and cylinder gas businesses and focus exclusively on large-scale industrial and energy projects. The pivot involved selling its industrial gases business in certain regions to Taiyo Nippon Sanso and acquiring assets for mega-scale green hydrogen projects. Air Products is betting its future on being the infrastructure provider for a hydrogen economy - building projects like NEOM in Saudi Arabia (a massive green hydrogen facility). This makes Air Products a competitor in Large Industries and hydrogen but not in merchant, healthcare, or electronics.

Messer Group is privately held (owned by the Messer family and CVC Capital Partners), headquartered in Germany. It is the fourth-largest player globally, with particular strength in Central and Eastern Europe, Germany, and Latin America (where it operates as White Martins in Brazil). Messer acquired Praxair's European and South American assets during the Linde-Praxair merger remediation, giving it scale. Because it is private, Messer can take a longer time horizon on investments, but the family ownership structure also limits its ability to make transformative acquisitions at the scale Linde or Air Liquide can pursue.

Nippon Sanso Holdings (Taiyo Nippon Sanso) is Japan's largest gas company and the fifth major global player, with particular strength in Japan, South Korea, and Southeast Asia. It operates in North America through its Matheson brand (acquired from Air Products). Before Air Liquide's DIG Airgas acquisition closed in January 2026, Nippon Sanso was the leading player in South Korea; Air Liquide's entry has reshuffled the competitive position there.

Barriers to entry. The industrial gas business has exceptional barriers:

1. Capital intensity: Building an air separation unit costs $50M-$300M+ depending on scale. A pipeline network connecting an industrial basin costs more. No single customer relationship justifies the infrastructure cost - you need the network.

2. Geographic specificity: Industrial gases have a natural "radius" - bulk liquid nitrogen is typically economic to deliver within 200-300 km of a production plant. Pipeline gas must obviously travel through owned pipe. This makes the business intensely local, and incumbents have the existing network.

3. Regulatory and safety: Gas handling facilities require regulatory permits, safety assessments, and environmental approvals that take years to obtain.

4. Customer qualification: Electronics and healthcare customers qualify suppliers through multi-year processes. The qualification history itself is a competitive asset.

5. Technical expertise: Operating cryogenic plants, managing hydrogen safely, producing NF3 to semiconductor purity - these are specialised capabilities built over decades.

Where Air Liquide wins. In healthcare, Air Liquide is in a category of one among major industrial gas companies. In US industrial distribution (through Airgas), the branch network gives it coverage and reach that competitors cannot easily match. In electronics, its semiconductor-grade gas manufacturing and precursor chemistry are differentiated from the two largest competitors. The ELYgator electrolyzer is one of the most ambitious single renewable hydrogen projects in Europe.

Where Air Liquide is exposed. In Europe, the combination of weak industrial demand and competition from Linde (in industrial supply) and Messer (in certain markets) limits growth. The margin gap with Linde remains real. In the merchant business, gas is gas - the differentiation is service, logistics, and price, not the molecule itself, which creates more competitive pressure than in Large Industries.

6. Industry

The industrial gases industry serves every major industrial sector simultaneously, which gives it a defensive quality that few basic materials businesses possess. When semiconductors are weak, healthcare grows. When European steel is soft, US semiconductor fabs are expanding. The portfolio effect across end markets is structural, not accidental.

Industry size and growth. The global industrial gases market stood at approximately $120-130 billion in 2025, growing at a compound annual rate of approximately 4.4-5.0%. Growth is driven by three structural forces: the industrialisation of emerging economies (primarily Southeast Asia and India), the semiconductor capex cycle which runs in 3-5 year waves, and the energy transition which is creating entirely new demand for industrial-scale hydrogen.

Supply chain position. Air Liquide sits in the middle of virtually every major industrial supply chain. Steel cannot be made without oxygen. Chips cannot be made without nitrogen and specialty gases. Hospitals cannot operate without medical gases. Food cannot be frozen or packaged at scale without nitrogen and CO2. The company is not a commodity input supplier in the sense of something easily substituted - it is a process-critical supplier whose output is embedded in the customer's production process.

Import dynamics. Industrial gases are not globally tradeable at scale. Oxygen and nitrogen are so cheap to produce (the raw material is air) that the economics of transoceanic shipping make no sense - the transport cost would exceed the product value many times over. Specialty electronics gases (NF3, WF6) are globally traded, but supply is concentrated in a handful of producers (including Air Liquide). Helium is the notable exception - it is traded globally because deposits are geographically concentrated (primarily US and Qatar) and quantities are small.

This non-tradeability is a structural protection. Import competition from lower-cost geographies is essentially impossible in the core atmospheric gas business. New tariffs (like those imposed by the Trump administration in 2025) affect Air Liquide through cost increases on steel and chemicals it sources, but not through import competition in its core gas business.

Regulatory environment. Each gas segment operates under different regulatory regimes. Medical gases are regulated as pharmaceuticals or medical devices in most jurisdictions - product approval, facility certification, batch testing. Industrial gases face environmental permits for ASU operations and pipeline infrastructure. Electronics gases face hazardous materials transport regulations and cleanroom qualification standards. Hydrogen infrastructure faces an evolving regime across the EU (the Hydrogen Bank, IPCEI, the European Hydrogen Backbone initiative), the US (DOE loan guarantees, IRA tax credits), and Asia (Korea's hydrogen roadmap, Japan's Green Innovation Fund). This regulatory complexity is a moat - navigating it at scale is itself a competitive capability.

Cyclicality. The business is less cyclical than it appears. Large Industries contracts are take-or-pay, so volumes are floor-protected in downturns. Healthcare demand is acyclical. Electronics demand tracks a semiconductor capex cycle, which is volatile in the short term but growing secularly. Industrial Merchant is the most cyclical element - demand falls when factories slow - but even here, diversification across 2 million customers across dozens of industries dampens the amplitude.

In the 2008-2009 financial crisis, Air Liquide's revenue fell modestly and recovered quickly. In the COVID period, healthcare revenue grew as hospitals expanded capacity, partially offsetting industrial softness. The business has not had a truly bad year in its 120-year history, which itself says something about the resilience of the demand structure.

Tailwinds. Three secular tailwinds are worth identifying:

1. Semiconductor investment wave: TSMC, Samsung, Intel, and Micron are all in multi-year, multi-hundred-billion-dollar fab expansion programs in the US, Europe, Japan, and Korea - all of which require gas supply infrastructure.

2. Industrial decarbonisation: Steel, cement, and chemical companies are under regulatory and investor pressure to reduce CO2 emissions. Many decarbonisation pathways require hydrogen (green or blue). Air Liquide is the infrastructure builder for those pathways.

3. Aging populations and home healthcare: Europe has an aging demographic that increases the prevalence of chronic respiratory disease and the political pressure on health systems to care for patients at home (cheaper than hospitals). Air Liquide's home healthcare model is aligned with the direction of healthcare policy across France, Germany, Spain, Italy, and beyond.

Headwinds. European industrial demand has been structurally weak since 2022, compressing Large Industries and merchant volumes in EMEA. Energy costs, while partially indexed in contracts, affect the economics of gas production. Geopolitical instability (the Middle East conflict, US tariff uncertainty, China supply chain concerns) creates an uncertain backdrop that management flagged explicitly in the Q1 2026 call.

7. Growth Triggers

The following triggers are sourced exclusively from the four concall transcripts reviewed. Each is cited by the call date.

From the Q1 2026 concall (April 28, 2026):

• DIG Airgas full-year contribution. The acquisition closed ahead of schedule in January 2026 and will contribute a full year's revenue in 2026, versus only a partial-year impact in prior guidance models. Management emphasised that accelerated closing means meaningful incremental contribution above original projections. (Q1 2026 concall, April 28, 2026)

• Record investment backlog at €5.5 billion. The backlog reached an all-time high in Q1 2026, up from €4.9 billion at Q3 2025 and €4.6 billion at H1 2025. Management described it as "a significant reservoir of growth that will translate into revenue and earnings." (Q1 2026 concall, April 28, 2026)

"Our project backlog has reached a historic height of EUR 5.5 billion, a significant reservoir of growth that will translate into revenue and earnings."

• Japan semiconductor investment (€200 million). Air Liquide announced in April 2026 a commitment to build and operate industrial gas production facilities in Japan to support "a world leader in semiconductors" producing next-generation AI chips. Operations expected to begin by end of 2028. This will add recurring Electronics revenue from 2028/2029 onward. (Q1 2026 concall, April 28, 2026)

• Hyundai Steel-POSCO Louisiana low-carbon steel plant. Air Liquide secured a contract to supply industrial gases for a new US joint venture between Hyundai Steel and POSCO, committing more than $350 million in investment. This will be the company's largest single US project investment and feeds directly into Large Industries revenue in the Americas from the late 2020s. (Q1 2026 concall, April 28, 2026)

• Taiwan Advanced Materials plant inauguration. A new production plant in Taiwan was inaugurated in Q1 2026, adding immediate capacity to serve the island's advanced semiconductor manufacturers (TSMC and its supply chain). (Q1 2026 concall, April 28, 2026)

• Operating efficiency ramp. Efficiencies of €142 million in Q1 2026 represent an 8% increase versus Q1 2025, on an already-record pace. Management expects the efficiency programme to continue driving margin improvement. (Q1 2026 concall, April 28, 2026)

From the FY 2025 concall (February 20, 2026):

• Extended margin ambition: +100 bps per year in 2026 and 2027. Having achieved +360 bps over 2022-2025, management announced a new two-year extension: +100 bps in 2026 and an additional +100 bps in 2027, for a total +560 bps from 2022-2027. This is a specific and unusual commitment - management has raised and then exceeded this target multiple times. (FY 2025 concall, February 20, 2026)

• ELYgator electrolyzer construction confirmed. The 200 MW electrolyzer at Rotterdam's Maasvlakte (more than €500 million investment) is in active construction and expected operational by end-2027. Once running, it will produce 23,000 tonnes of renewable hydrogen annually, feeding industrial customers and heavy-duty mobility users. (FY 2025 concall, February 20, 2026)

• Free share attribution: one share per ten, June 2026. Management confirmed a free share attribution program to be executed in June 2026 - a loyalty mechanism Air Liquide uses periodically to reward long-term shareholders. (FY 2025 concall, February 20, 2026)

• Record efficiencies of €631 million (+27% vs 2024) confirm industrial transformation is working. Management described the efficiency programme (implemented mid-2024) as now deeply embedded in operations, with continued momentum expected through 2026-2027. (FY 2025 concall, February 20, 2026)

From the Q3 2025 (9-month) concall (October 28, 2025):

• Healthcare growing 4.9% comparable, "disconnected from industrial trends." Management explicitly framed Healthcare as a structural growth engine independent of the macro cycle - 2.3 million chronic patients, demographics, and home-first healthcare policy direction. (Q3 2025 concall, October 28, 2025)

• 9-month efficiencies at €434 million (+22.9% vs prior year), efficiency rate at record 23%. The efficiency programme was ahead of pace, suggesting the full-year 2025 will beat the previous record. This was reiterated at FY 2025. (Q3 2025 concall, October 28, 2025)

• Americas region +4.8% - the growth engine in Q3. Americas driven by project start-ups and the Airgas commercial machine, indicating sequential improvement and pipeline of ramp-ups contributing to 2025-2026 revenue. (Q3 2025 concall, October 28, 2025)

• Backlog at €4.9 billion (record at the time). Sequential growth in backlog is the most direct leading indicator of future revenue ramp-up. (Q3 2025 concall, October 28, 2025)

From the H1 2025 concall (July 29, 2025):

• Investment backlog at record €4.6 billion, with ~€1.6 billion in Electronics and ~€2.0 billion in energy transition. Composition of backlog confirms secular growth drivers: chip fabs and hydrogen transition are the two largest components. (H1 2025 concall, July 29, 2025)

• Investment decisions of €2.3 billion in H1 2025 (+39% vs H1 2024). Record pace of project wins and FIDs signals revenue ramp-up across 2026-2028. (H1 2025 concall, July 29, 2025)

• Engineering & Technologies order intake of €1,307 million (+38% YoY). External engineering orders for hydrogen plants and industrial decarbonisation projects reflect market demand for infrastructure that Air Liquide uniquely can build. (H1 2025 concall, July 29, 2025)

• Carrier gas sales in Electronics +10%. Underlying semiconductor gas demand is growing at double digits, separate from the lumpy equipment/installation line. (H1 2025 concall, July 29, 2025)

• Germany semiconductor cluster investment (€250M+). Air Liquide's largest European Electronics project - three ASUs and two hydrogen production units in Silicon Saxony (Dresden) - is under construction, operational target 2027. (H1 2025 concall, July 29, 2025)

• Ramp-up contributions expected €310-340 million for full year 2025. This is incremental revenue from plant start-ups already decided and under construction, effectively guaranteed revenue from committed capital. (H1 2025 concall, July 29, 2025)

• Two electrolyzer projects in Netherlands (ELYgator + TotalEnergies JV, combined 450 MW). Final investment decision taken in July 2025 for ELYgator; JV announced in February 2025. Together, the most ambitious renewable hydrogen infrastructure buildout in Air Liquide's history. (H1 2025 concall, July 29, 2025)

Trigger summary table:

8. Key Risks

1. European industrial demand continues to deteriorate. Mechanism: Europe's industrial base - chemicals, steel, refining - has been under pressure since 2022 from high energy costs, subdued export demand from China, and the slow shutdown of energy-intensive capacity. If this structural decline accelerates, Air Liquide's EMEA Large Industries and merchant businesses face volume pressure. Take-or-pay contracts provide a floor, but customers in financial difficulty can renegotiate or default. Germany is a particular concern - the most gas-intensive economy in Europe is also the most exposed to energy transition pain. Calibration: Moderate probability, moderate-to-significant impact. EMEA is approximately 41% of revenues; Large Industries is a significant fraction of that. The margin improvement programme was partly designed to offset this risk by replacing volume growth with efficiency gains.

2. Currency headwind from a strong euro. Mechanism: Air Liquide reports in euros but generates approximately 60% of revenue outside the eurozone - primarily in US dollars, Korean won, Chinese renminbi, and Japanese yen. A strengthening euro against the dollar is the most material exposure. In Q3 2025, the reported revenue line was -2.4% despite comparable growth of +1.9%, almost entirely due to a -4.2% currency drag. If the euro continues to strengthen against the dollar (plausible in a US tariff recession scenario), the gap between comparable and reported performance grows. Calibration: High probability of ongoing impact, moderate drag (it reduces reported numbers but not the operational reality of the business). Management addresses it by guiding to constant-currency terms, but shareholders feel currency drag in dividends and reported EPS.

3. Tariff and geopolitical disruption affecting US operations. Mechanism: The Trump administration's broad tariff programme (referenced by management in the Q1 2026 call) creates several indirect exposures. Steel and aluminium tariffs raise the cost of capital equipment for Air Liquide's US construction projects. Tariff-driven economic slowdown in the US reduces merchant volumes. Retaliation against US goods by trading partners could reduce activity at US-based manufacturing customers who export. Calibration: CEO Jackow specifically named "geopolitical instability" in the Q1 2026 call as the primary macro concern. The risk is real but difficult to quantify. Air Liquide's US businesses are primarily domestic suppliers (not exporters), so direct trade exposure is limited.

"In a context of geopolitical instability marked in particular by the conflict in the Middle East" - F. Jackow, Q1 2026 concall, April 28, 2026

4. DIG Airgas integration risk. Mechanism: Acquiring a €2.85 billion business in South Korea - a country where Air Liquide was not the market leader - is operationally complex. Korea has distinct labour relations, regulatory requirements, and customer relationship norms. Integration of systems, cultures, and commercial practices is never frictionless. If synergies are slower than expected, or if integration disrupts existing DIG customer relationships, the financial case for the acquisition degrades. Calibration: Moderate probability of friction, limited catastrophic risk. Air Liquide has strong M&A integration capabilities (the Airgas integration in 2016 was its largest-ever acquisition and proceeded successfully). The DIG business is also already a well-run, profitable operation rather than a turnaround.

5. Electronics capex downturn. Mechanism: Semiconductor investment cycles are volatile. A demand slowdown in AI hardware, memory, or consumer electronics can cascade quickly into reduced wafer starts, which reduces carrier gas consumption. More significantly, a pause in fab construction - fabs that Air Liquide is investing ahead of - would strand committed capital. Air Liquide disclosed that its backlog includes ~€1.6 billion in Electronics, all of which presumes fabs are built and operate at expected volumes. Calibration: Moderate probability (cycles happen), significant impact on a 9% of revenue segment and on the long-term compounding story. The current AI chip investment cycle (driven by TSMC, Samsung, SK Hynix racing to build capacity for AI accelerators) appears robust, but any sustained slowdown in AI infrastructure spending would be felt.

6. Green hydrogen economics uncertainty. Mechanism: Air Liquide is committing over €500 million to ELYgator alone and has a total energy transition backlog of approximately €2 billion. Green hydrogen is only economic if electricity costs are low enough and if the delivered hydrogen price competes with grey hydrogen (natural gas-based). If electricity prices remain elevated, if carbon pricing does not rise enough to penalise grey hydrogen, or if demand from industrial customers materialises more slowly than expected, Air Liquide's large-scale electrolysis investments could generate below-expected returns. Calibration: Real and underappreciated risk. The economics of green hydrogen at scale are not yet proven. Air Liquide mitigates by securing long-term offtake agreements (TotalEnergies for ELYgator) before taking FID, but the projects are still dependent on regulatory support (Dutch OWE subsidies, European Innovation Fund grants) that could change.

7. Pricing erosion in Industrial Merchant. Mechanism: Industrial Merchant pricing is the most market-exposed element of the portfolio. Air Liquide has been pushing 2-3% annual price increases in this segment, but if competition intensifies, if industrial customers gain purchasing power through consolidation, or if deflation hits feedstock-intensive industries, pricing power may erode. The margin improvement programme depends partly on pricing discipline being sustained. Calibration: Low-to-moderate probability in current environment, moderate impact on a large (46% of revenue) segment.

9. Walk the Talk

Concall dates reviewed:

1. Q1 2026 - April 28, 2026 (19 days before this report date - most recent)
2. FY 2025 - February 20, 2026
3. Q3 2025 (nine-month revenue) - October 28, 2025
4. H1 2025 - July 29, 2025

Air Liquide's management credibility is best understood through the ADVANCE plan, which ran from 2022 to 2025 and provided a rare, multi-year scoreboard against which to measure promises.

Setting the promise (2022). When the ADVANCE plan was launched in March 2022, management set a margin improvement target of +160 basis points over four years. That was the commitment on the table. A mid-range target - not conservative, but not aggressive.

Raising the target twice. By the time of the H1 2025 concall, management had already raised the margin target twice. In February 2024, the revised target was +320 bps. By early 2025, the ambition was +460 bps over five years. This pattern - setting a target, delivering early, raising the target - repeated across four years.

"Our performance confirms the resilience and the adaptability of our model. Quarter after quarter, Air Liquide stays the course and continues to achieve a very solid financial performance." - F. Jackow, H1 2025 concall, July 29, 2025

Delivery at FY 2025. The FY 2025 concall (February 20, 2026) disclosed the final result: +360 bps cumulative margin improvement over 2022-2025, exceeding even the twice-raised target of +320 bps. The recurring ROCE target (>10% from 2023) was hit one year early at 10.2% in 2024 and rose to 11.2% in 2025. Revenue CAGR of +6.1% versus the +5-6% target. CO2 reduction of -13% versus a -25% intensity target that was already being met. This is a clean sweep.

What changed along the way. Management acknowledged at Q3 2025 that comparable revenue growth was a "resilient" +1.9% despite a challenging macro environment in Europe. The honest framing matters: they did not pretend the environment was better than it was. Volume headwinds in EMEA Large Industries and electronics equipment cyclicality were disclosed clearly each quarter, alongside the operational levers (pricing, efficiency) that were working.

The DIG Airgas commitment. The deal was announced August 2025 and guided to close in Q1 2026. It closed on January 13, 2026 - ahead of schedule. Management noted in the Q1 2026 call that this means full-year contribution in 2026 rather than the partial year originally modelled. A promise delivered early.

The extension into 2026-2027. At the FY 2025 call, management committed to +100 bps margin improvement in both 2026 and 2027. This is a specific, trackable commitment. The Q1 2026 call confirmed it is on track - with operating efficiencies already running at a +8% pace versus Q1 2025. The backlog at €5.5 billion provides the growth fuel, and the efficiency programme provides the margin lever.

Areas of less-perfect delivery. The EMEA region has consistently underdelivered relative to the Americas and Asia. European industrial weakness was consistently cited as a headwind, and management has navigated around it rather than solved it. Electronics equipment revenue has been lumpy - H1 2025 showed flat reported growth despite strong underlying carrier gas demand. Management's guidance on comparable versus reported growth has sometimes created confusion when currency effects were unusually large (Q3 2025 showed -2.4% reported vs +1.9% comparable).

Assessment. This is management that consistently does what it says - and then raises the bar and does more. Four years of the ADVANCE plan provide a clean record: every major commitment was met or exceeded. The credibility on the 2026-2027 margin target is high, grounded in a backlog at record levels and an efficiency programme operating ahead of pace. The main caveat is that macro conditions in Europe are genuinely difficult, and management's tone is appropriately measured about volume growth while confident on margin.

10. Shareholder Friendliness Index

Dividends. Air Liquide has not cut its dividend in at least 50 years. Over the past 30 years, the per-share dividend has compounded at approximately 9.2% annually. In recent years, growth has accelerated: €2.40 per share in 2022, €2.68 in 2023, €2.91 in 2024, and €3.30 in 2025 - a 12.1% increase in a single year. The Board proposed €3.70 per share for 2026, another 12.1% rise, confirmed at the FY 2025 annual results. The payout ratio stands at approximately 55%, providing ample coverage. Air Liquide also supplements cash dividends with periodic free share attributions: one new share per ten held was distributed in June 2024 and again in June 2026, effectively adding ~10% to any long-term holder's position tax-efficiently (subject to French tax rules).

Buybacks and dilution. Air Liquide runs a share buyback programme, though the scale is modest relative to the company's size. In December 2024, the company repurchased 352,000 shares (0.07% of capital) under a settlement agreement. In February-March 2026, a programme authorised at the May 2025 AGM resulted in the repurchase of 964,000 shares (0.17% of capital) for approximately €167 million. Shares outstanding have been broadly stable at approximately 2.62 billion from 2022-2023, rising to approximately 2.88-2.89 billion in 2024-2025 following the June 2024 free share attribution (which added approximately 10% to the total count). The free share programme, while shareholder-friendly in its intent, mechanically dilutes EPS unless offset by buybacks. Buyback activity is insufficient to fully offset the dilution from the attribution - management's primary return mechanism is the dividend, not repurchases.

Verdict: Returns Capital - Air Liquide prioritises dividends (12% annual growth, 50+ years uninterrupted) over buybacks, supplemented by periodic free share attributions that reward long-term holders.

11. Insider Activities

Source: ABC Bourse (aggregator of AMF directors' dealings declarations, France). All transactions are covered by EU Market Abuse Regulation Art. 19, requiring PDMR declaration within 3 business days. Primary regulator: AMF (Autorité des Marchés Financiers).

Recent transactions (most recent first):

Buys - reading the signal. The only purchase in the trailing twelve months is Jérôme Pelletan's €8,791 subscription through an employee capital increase programme in December 2025 - 63 shares at €139.54. This is a mechanical subscription to an employee savings plan, not an open-market conviction buy. It is not a meaningful signal.

Sells - working out the why. The selling pattern at Air Liquide is textbook executive compensation monetisation. Benoît Potier's March 2025 and March 2026 transactions follow an identical sequence: exercise stock options granted years earlier at a historical low strike price (€62.86-€69.12 in 2026, versus the prevailing market price of approximately €172-€176), then immediately sell a portion of the acquired shares in the market. This is a tax-efficient compensation structure commonly used by French corporates. The retained shares (exercise minus sale) remain Potier's equity exposure. There is no disclosed reason for the specific timing other than the option grant schedule; this pattern has been consistent for years.

François Jackow's sales are smaller, distributed across the year (typically 1,000-2,000 shares per quarter), and appear consistent with a regular vesting/monetisation schedule for his long-term incentive compensation. They are not concentrated at obvious price peaks, do not cluster around negative announcements, and are small in scale relative to his presumed equity position.

Net assessment. Air Liquide's insider activity over the last twelve months is neutral-to-slightly-cautious in signal. All selling activity is attributable to routine compensation liquidation rather than to insider pessimism about the business. The absence of any meaningful open-market purchases by senior executives means there is no bullish signal from insider buying. In the context of a company that has consistently raised its targets and beaten them, the lack of executive buying is mildly notable but not alarming - it may simply reflect that at €172-€186 per share, executives feel their existing compensation holdings are sufficient equity exposure.

12. Scenarios

Bull Case

The semiconductor investment wave lasts longer and runs larger than the base case assumes. TSMC, Samsung, and SK Hynix continue to expand fab capacity in the US, Japan, Korea, and Europe through 2028-2030, and each new fab is a long-term contract for Air Liquide's Electronics segment. The Germany Silicon Saxony complex comes online in 2027 on schedule, the Japan plant follows in 2028, and the Taiwan and Singapore plants operating in 2026 hit expected volumes. Electronics carrier gas volumes grow at double digits for a sustained period.

Simultaneously, Europe's industrial decarbonisation agenda accelerates rather than stalls. The ELYgator electrolyzer and the TotalEnergies JV both operate at full capacity from 2028, and the demand for renewable hydrogen from industrial customers - steel, chemicals, mobility - exceeds initial expectations as carbon prices rise and corporate decarbonisation commitments become binding. Air Liquide captures the central infrastructure position in Europe's emerging hydrogen economy, winning follow-on electrolyzer and hydrogen distribution contracts that dwarf the current backlog.

The DIG Airgas integration goes smoothly, South Korea's semiconductor and steel industries expand as expected, and Air Liquide earns a market-leader premium in a market that has historically been dominated by local players. Healthcare continues its 4-5% structural growth as European demographics drive demand and Spain, France, Germany, and Italy all expand home-first healthcare policies. The ADVANCE efficiency programme compounds, margin improves beyond the +560 bps target to approach Linde's historically superior margin level, and Air Liquide's relative discount to Linde closes.

In this scenario, Air Liquide is a compounder - one of those rare businesses that grows earnings at high single digits annually for a decade through a combination of volume, price, and margin expansion, while paying a growing dividend that covers a meaningful portion of the return.

Base Case

Management delivers broadly what it has guided. Operating margin improves by approximately 100 basis points in each of 2026 and 2027, consistent with the explicit commitment made at the February 2026 annual results. The investment backlog of €5.5 billion converts steadily to revenue over 2026-2029, with ramp-up contributions providing a predictable growth layer each year even if new commercial wins slow.

Electronics grows, but with the usual lumpiness from equipment revenue cyclicality. Carrier gas sales continue at high single digits, but one or two of the planned fab projects experiences a delay of 12-18 months - not unusual in large semiconductor construction. Healthcare remains the most reliable growth engine at 4-5% comparable, providing the portfolio's defensive floor. Industrial Merchant in Europe stabilises rather than declining, as some capacity rationalisation among European manufacturers reduces the pool of active customers but also reduces competitive pressure from weaker players.

DIG Airgas integrates well enough - synergies take longer than expected but materialise by 2027. The Louisiana steel plant breaks ground and proceeds on schedule, adding to the Americas Large Industries position from 2028.

In this scenario, Air Liquide is a reliable, growing industrial compounder - not exciting at any individual moment but steadily building enterprise value, growing its dividend, and maintaining the trust of long-term investors. The efficiency programme alone provides a meaningful income stream that does not depend on volume growth.

Bear Case

European industrial recession deepens significantly. Germany's energy-intensive manufacturing sector accelerates its shift of capacity to Asia and the US, reducing demand for industrial gases along Air Liquide's largest pipeline networks in EMEA. Take-or-pay contracts provide temporary protection, but customers in genuine distress negotiate payment relief or restructure. EMEA Large Industries revenue declines for multiple consecutive years, and the Industrial Merchant market in France, Germany, and Italy sees sustained volume pressure as factories run at reduced utilisation.

Simultaneously, the AI chip investment cycle peaks earlier than expected - driven by an AI hardware spending pause from hyperscalers who have built faster than their model utilisation justifies. Semiconductor fab construction slowdowns across TSMC's US sites, and SK Hynix and Samsung cut their capex guidance for 2027-2028. The Electronics backlog does not convert to revenue on schedule, and some planned investments are deferred.

In this scenario, the back-end of the investment backlog - the projects expected to convert in 2027-2029 - faces more uncertainty than current management guidance implies. The ELYgator project operates but at lower utilisation than expected because industrial hydrogen demand, while growing, comes on slower than the green transition narrative projected. Renewable hydrogen remains more expensive than grey hydrogen for most industrial users without further regulatory support.

Currency compounds the damage: the euro strengthens against the dollar as the Federal Reserve cuts rates into a US slowdown, shrinking the reported-currency value of Air Liquide's 39% Americas revenues.

Air Liquide does not face a business model crisis in this scenario. The take-or-pay structure in Large Industries, the acyclicality of Healthcare, and the long-term contracts in Electronics mean the business generates cash through downturns. But the growth narrative slows materially, the backlog conversion extends in time, and the 2026-2027 margin targets become harder to hit through efficiency alone without volume support. The dividend continues growing but at a slower pace, and the stock re-rates down from its premium multiple.

Sources:

• First Quarter 2026 Revenue - Air Liquide
• Growth, Performance and Record Investments: Q1 2026 Press Release
• 2025 Annual Results - Air Liquide IR
• FY 2025 Press Release: Record Performance
• Q3 2025 Revenue Press Release
• H1 2025 Results Press Release
• H1 2025 Financial Report (PDF)
• ADVANCE Strategic Plan - Air Liquide
• Air Liquide in Brief
• DIG Airgas Acquisition Closing - January 2026
• DIG Airgas Announcement - August 2025
• ELYgator Final Investment Decision - July 2025
• Japan Semiconductor Investment - April 2026
• Germany Semiconductor Investment - July 2025
• Air Liquide Healthcare Activities
• Air Liquide Wikipedia
• Industrial Gases Market Analysis - Grand View Research
• Industrial Gases: A Resilient Industry - Econopolis
• Air Liquide Insider Transactions - ABC Bourse/AMF
• Air Liquide Dividend History - StockAnalysis
• Air Liquide Share Buyback - Business Wire
• L'Air Liquide Q4 2025 Earnings Call - Seeking Alpha
• Air Liquide H1 2025 Earnings Call Highlights - Yahoo Finance
• Air Liquide Q1 2026 Earnings Call Transcript - Yahoo Finance
• Air Liquide Large Industries
• Air Liquide Electronics
• Markets and Markets - Industrial Gases
• Air Liquide 2025 Integrated Annual Report